NASDAQ: TEMTempus Ai Inc Stock
$51.67-2.62 (-4.83%)
Updated Apr 30, 2025
TEM Price
$51.67
Fair Value Price
-$31.71
Market Cap
$8.90B
52 Week Low
$22.89
52 Week High
$91.45
P/E
-8.29x
P/B
157.94x
P/S
5.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$693.40M
Earnings
-$705.81M
Gross Margin
55%
Operating Margin
-94.01%
Profit Margin
-107.6%
Debt to Equity
15.44
Operating Cash Flow
-$189M
Beta
2.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TEM Overview
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TEM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Internet Content & Information
Industry Rating
B
TEM
Ranked#38 of 51
Ranked#38 of 51
Be the first to know about important TEM news, forecast changes, insider trades & much more!
TEM News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TEM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TEM ($51.67) is overvalued by 262.95% relative to our estimate of its Fair Value price of -$31.71 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TEM ($51.67) is not significantly undervalued (262.95%) relative to our estimate of its Fair Value price of -$31.71 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TEM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TEM due diligence checks available for Premium users.
Valuation
TEM fair value
Fair Value of TEM stock based on Discounted Cash Flow (DCF)
Price
$51.67
Fair Value
-$31.71
Undervalued by
262.95%
TEM ($51.67) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TEM ($51.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TEM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TEM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.29x
Industry
33.32x
Market
29.18x
TEM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
157.94x
Industry
5.78x
TEM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TEM's financial health
Profit margin
Revenue
$200.7M
Net Income
-$13.0M
Profit Margin
-6.5%
TEM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TEM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$926.1M
Liabilities
$869.8M
Debt to equity
15.44
TEM's short-term assets ($667.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TEM's short-term assets ($667.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TEM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$39.3M
Investing
-$8.0M
Financing
-$179.0k
TEM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TEM vs Internet Content & Information Stocks
Tempus Ai Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.